Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM-1 vs Active Comparator in Transient Insomnia
NCT04396327Phase 2Not yet recruiting
- Sponsor
- Sequential Medicine Ltd.
- Start
- May 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of SM-1 in Insomnia, sponsored by Sequential Medicine Ltd.. Planned start May 2020; status: not yet recruiting.
02
Drugs
SM-1
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04396327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04396327.